Morgans has given its verdict on a few popular ASX 200 stocks this week, courtesy of The Bull.
Let's see how it rates them:
Image source: Getty Images
BHP Group Ltd (ASX: BHP)
Morgans is a fan of this mining giant. It likes its diversified operations, strong balance sheet, and disciplined capital management.
However, the main attraction appears to be copper, which the broker expects to be a key earnings driver thanks to the electrification megatrend.
However, given recent strength in BHP shares, Morgans thinks that they are fairly valued rather than offering a compelling buying opportunity. As a result, the broker has named BHP as a hold this week.
Commenting on its recommendation, Morgans said:
BHP provides diversified exposure to iron ore, copper and future-facing commodities, backed by a strong balance sheet and disciplined capital management. Copper offers long term appeal through electrification, while iron ore continues to drive near term earnings. However, results remain sensitive to global growth and Chinese demand.
With commodity prices reflecting mixed economic signals, BHP's valuation looks fair rather than compelling. BHP suits investors seeking stability and income, but upside appears balanced by cyclical risk, supporting a hold rating.
Sigma Healthcare Ltd (ASX: SIG)
Morgans is far more positive on the investment opportunity with Sigma Healthcare shares.
It believes the Chemist Warehouse owner is well-placed to deliver margin improvement through own label expansion and exclusive products.
The broker also sees opportunities for the company to improve operating leverage with supply chain efficiencies and the consolidation of distribution centres following its merger.
So, with Sigma Healthcare shares trading closer to their 52-week low than their 52-week high, Morgans thinks now could be an opportune time to snap up shares. As a result, it has named the company as a buy this week.
Commenting on the opportunity, the broker said:
SIG is a leading wholesale distributor and retail pharmacy franchisor with operations in Australia, New Zealand, Ireland and the United Arab Emirates. It has a solid balance sheet with conservative leverage and strong operating cash flows. We believe SIG can continue to widen margins through expanding labels it owns and exclusive products.
We expect improving operating leverage through efficiencies in the supply chain and consolidation in distribution centres. A softer share price provides a compelling buying opportunity for long term focused investors.
